Evidence map›Paper›PMID 33369074›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2021

India Hypertension Control Initiative-Hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics.

Prabhdeep Kaur, Abhishek Kunwar, Meenakshi Sharma, Jhilam Mitra, Chinmoyee Das, Leimapokpam Swasticharan, Tapas Chakma, Sampada Dipak Bangar, Vettrichelvan Venkatasamy, Raviteja Dharamsoth and 24 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04992039 (Evaluation of the WHO HEARTS Hypertension Control Package in the Primary Care Clinics of Bangladesh), which is not on this map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04992039 nacompletednot on this map

Evaluation of the WHO HEARTS Hypertension Control Package in the Primary Care Clinics of Bangladesh: A Quasi-experimental Trial

TypeinterventionalSponsorNational Heart Foundation of BangladeshRan2021 to 2022Enrolled3,935ConditionsHypertensionArmsWHO HEARTS technical package
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 11 institutions in 2 countries.

Prabhdeep KaurICMR-National Institute of Epidemiology, Chennai, India.
Abhishek KunwarWHO Country Office for India, New Delhi, India.
Meenakshi SharmaIndian Council of Medical Research (ICMR), New Delhi, India.
Jhilam MitraICMR-National Institute of Epidemiology, Chennai, India.
Chinmoyee DasDirectorate General of Health Services I Ministry of Health and Family Welfare, New Delhi, India.
Leimapokpam SwasticharanDirectorate General of Health Services I Ministry of Health and Family Welfare, New Delhi, India.
Tapas ChakmaICMR-National Institute of Research in Tribal Health, Jabalpur, India.
Sampada Dipak BangarICMR-National AIDS Research Institute, Pune, India.
Vettrichelvan VenkatasamyICMR-National Institute of Epidemiology, Chennai, India.
Raviteja DharamsothState NCD Cell, Department of Health, Medical and Family Welfare, Govt of Telangana, Hyderabad, India.
Saurabh PurohitState NCD Cell, Directorate of Health Services, Govt of Madhya Pradesh, Bhopal, India.
Sadhana TayadeState NCD Cell, Directorate of Health Services, Govt of Maharashtra, Mumbai, India.
Gurinder B SinghState NCD Cell, Department of Health and Family Welfare, Govt of Punjab, Chandigarh, India.
Sailaja BitraguntaICMR-National Institute of Epidemiology, Chennai, India.
Kiran DurgadWHO Country Office for India, New Delhi, India.
Bidisha DasWHO IHCI Project, Punjab, India.
Sunil DarWHO IHCI Project, Punjab, India.
Rupali BharadwajWHO IHCI Project, Madhya Pradesh, India.
Chakshu JoshiWHO IHCI Project, Madhya Pradesh, India.
Vishwajit BharadwajWHO IHCI Project, Maharashtra, India.
Suhas KhedkarWHO IHCI Project, Maharashtra, India.
Sravan ChenjiWHO IHCI Project, Telangana, India.
Sravan K ReddyWHO IHCI Project, Telangana, India.
Chintala SreedharWHO IHCI Project, Telangana, India.
Ganeshkumar ParasuramanICMR-National Institute of Epidemiology, Chennai, India.
Savitha KasiviswanathanICMR-National Institute of Epidemiology, Chennai, India.
Vidhya ViswanathanICMR-National Institute of Epidemiology, Chennai, India.
Pankaj UikeICMR-National Institute of Research in Tribal Health, Jabalpur, India.
Pooja GaigawareICMR-National AIDS Research Institute, Pune, India.
Suniti YadavIndian Council of Medical Research (ICMR), New Delhi, India.
R S DhaliwalIndian Council of Medical Research (ICMR), New Delhi, India.
Sivasubramanian RamakrishnanAll India Institute of Medical Sciences, New Delhi, India.
Fikru T TulluWHO Country Office for India, New Delhi, India.
Balram BhargavaIndian Council of Medical Research (ICMR), New Delhi, India.
World Health Organization - India · INNational Institute of Epidemiology · INIndian Council of Medical Research · INDepartment of Health & Family Welfare · INMinistry of Health and Family Welfare · INNational AIDS Research Institute · INNational Institute for Research in Tribal Health · INPunjab Technical University · INAll India Institute of Medical Sciences · INDirectorate of Health · ISGovernment of Maharashtra · IN

Funding

World Health Organization 001
6 · The paper itself

Abstract

The India Hypertension Control Initiative (IHCI) is a multi-partner initiative, implementing and scaling up a public health hypertension control program across India. A cohort of 21,895 adult hypertension patients in 24 IHCI sentinel site facilities in four Indian states (Punjab, Madhya Pradesh, Maharashtra, and Telangana), registered from January 2018 until June 2019 were assessed at baseline and then followed up for blood pressure (BP) control and antihypertensive medication use. Among all registrations, 11 274 (51%) of the patients returned for a follow-up visit between July 2019 and September 2019. Among patients returning for follow-up, 26.3% had BP controlled at registration, and 59.8% had BP controlled at follow-up (p < .001). The absolute improvement in BP control was more than two times greater in primary care (48.1 percentage point increase) than secondary care facilities (22.9 percentage point increase). Most IHCI patients received prescriptions according to state-specific treatment protocols. This study demonstrates that a scalable public health hypertension control program can yield substantial BP control improvements, especially in primary care settings. However, high loss to follow-up limits population health impact; future efforts should focus on improving systems to increase the likelihood that patients will return to the clinic for routine hypertension care.

Indexed as

HypertensionAdultAntihypertensive AgentsBlood PressureHumansIndiaPrimary Health CareAntihypertensive Agentshypertension controlIndianoncommunicable diseasesraised blood pressure

Identifiers

PMID33369074
PMCPMC8678731
OpenAlexW3116451731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.